Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Killa acne extra strength - Medication Information

Product NDC Code 81746-420
Drug Name

Killa acne extra strength

Type Brand
Active Ingredients
Salicylic acid .0125 mg/.6216mg
Route TOPICAL
Dosage Form PATCH
RxCUI drug identifier 1546588
Application Number M006
Labeler Name Zitsticka, Inc.
Packages
Package NDC Code Description
81746-420-01 3220 mg in 1 box (81746-420-01)
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active Ingredients Salicylic Acid 2%

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
NA NA

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive Ingredients Inactive Ingredients: Sodium Hyaluronate, Phytosphingosine HCL, Niacinamide, Oligopeptide-10, Glycolic Acid, Madecassoside, 4-Butylresorcinol. Patch: Hydrocolloid

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses Uses: For the management of acne. Penetrates pores to eliminate most blemishes

Purpose

Information about the drug product’s indications for use.
Purpose Acne Treatment

Spl product data elements

Usually a list of ingredients in a drug product.
Killa Acne Extra Strength Salicylic Acid OLIGOPEPTIDE-10 NIACINAMIDE GLYCOLIC ACID 4-BUTYLRESORCINOL SALICYLIC ACID SALICYLIC ACID HYALURONATE SODIUM MADECASSOSIDE PHYTOSPHINGOSINE HYDROCHLORIDE

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
Killa Acne ES PDP KAES 4 Pack PDP

Ask doctor

Information about when a doctor should be consulted about existing conditions or sumptoms before using the drug product, including all warnings for persons with certain preexisting conditions (excluding pregnancy) and all warnings for persons experiencing certain symptoms. The warnings under this heading are those intended only for situations in which consumers should not use the product until a doctor is consulted.
Ask a doctor If irritation becomes severe

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children If swallowed, get medical help or contact a Posion Control Center right away.

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product Skin irritation and dryness may occur if you use another topical acne medication at the same time or immediately following. If irritation occurs, only use one topical acne medication at a time unless directed by a doctor.

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings For extrernal use only

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API